Loading filters...
Publications per Year (3419 total)
13
1990
18
·
23
·
29
·
37
·
34
1995
36
·
33
·
62
·
61
·
56
2000
69
·
98
·
88
·
110
·
108
2005
122
·
120
·
119
·
137
·
133
2010
155
·
178
·
205
·
75
·
41
2015
47
·
41
·
27
·
29
·
1
2020
375
·
272
·
293
·
97
·
4
2025
73
·
Loaded
Click to load
50 / 3419 papers loaded(scroll for more)
202650 papers
HPV-relatedAll Stages2026
Mouse Vocal Fold Permeability In Vivo: Effects of Novel Low-Tech Injury and Instillation Methods.
King RE et al. Laryngoscope. 2026
HPV-relatedAll Stages2026
Obstructive Sleep Apnea in Head and Neck Cancer Patients After Primary Treatment: A Review Focused on Oropharyngeal Cancer.
Patel N et al. Head Neck. 2026
HPV-relatedEarly (I-II)2026
Risk of Occult Contralateral Neck Metastasis in Early-Stage HPV-Related Lateralized Cancer of the Base of the Tongue.
Halle TR et al. Head Neck. 2026
HPV-relatedAll Stages2026
Transoral Robotic Surgery (TORS) for Head and Neck Cancer in the Elderly Population: Functional Outcomes, Survival, and Complications.
Pamuk E et al. Head Neck. 2026
Anti-EGFRAll Stages2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion).
Economopoulou P et al. Oral Oncol. 2026
laryngealAll Stages2026
Missed Opportunities: Laryngologists and Lung Cancer Screening in Early Glottic Cancer Patients.
Stack TJ et al. Laryngoscope. 2026
GeneralAll Stages2026
Swallowing-related outcomes and organ-at-risk dosimetry after proton versus photon radiotherapy in nasopharyngeal carcinoma.
Huang YJ et al. Oral Oncol. 2026
laryngealEarly (I-II)2026
Surgical outcomes of modified versus conventional transoral endoscopic thyroidectomy vestibular approach for papillary thyroid carcinoma.
Ngo DQ et al. Oral Oncol. 2026
Anti-EGFREarly (I-II)2026
Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer.
Birkenbeuel JL et al. JAMA Otolaryngol Head Neck Surg. 2026
HPV-relatedAll Stages2026
Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.
Mascarella MA et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
EPIDERM Technique: Safety and Outcomes of Skin Grafted Free Flaps in Head and Neck Reconstruction.
Patel N et al. Laryngoscope. 2026
laryngealAll Stages2026
The Application of Radiomics in Laryngeal Cancer Management: A Scoping Review of the Literature.
Papadopoulou AM et al. Laryngoscope. 2026
GeneralAll Stages2026
Appraisal of Radiologic Size Criteria for Malignant Lymph Nodes in Parotid Region in Nasopharyngeal Carcinoma: Implication for Parotid-Sparing IMRT.
Guo Q et al. Head Neck. 2026
laryngealAll Stages2026
An Isolated Soft Tissue Ectopic Paraganglioma in the Head and Neck.
Sayeed S et al. Head Neck. 2026
GeneralAll Stages2026
Low-dose fractionated radiotherapy combined with induction chemotherapy in high-risk nasopharyngeal carcinoma: An open-label, randomized phase 2 trial.
Fan M et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Does discharge location following head and neck cancer surgery affect quality outcomes?
Benites C et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
From heterogeneity to molecular stratification: A multiplex genomic panel for tailored therapy of head and neck squamous cell carcinoma.
Margoni A et al. Oral Oncol. 2026
Generaladvanced2026
Disease control with disitamab vedotin in HER2-low polymorphous adenocarcinoma of the tongue base after chemotherapy failure: A case report.
Liu H et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Postoperative Effects of Celecoxib on Opioid Use and Pain Control After Benign Oropharyngeal Surgery.
Platukus A et al. Laryngoscope. 2026
ImmunotherapyAll Stages2026
Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.
Gabra L et al. JAMA Otolaryngol Head Neck Surg. 2026
HPV-relatedEarly (I-II)2026
Basaloid Squamous Cell Carcinoma of the Midline Dorsal Tongue: Case Report and Review of the Literature.
Kapustin JE et al. Head Neck. 2026
HPV-relatedAll Stages2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.
Vemulamanda S et al. Clin Cancer Res. 2026
laryngealadvanced2026
Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy.
Holgado A et al. Oral Oncol. 2026
laryngealEarly (I-II)2026
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinoma.
Cracchiolo JR et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Longitudinal Analysis of Oral Potentially Malignant Disorder Conversion to Malignancy.
Palatnik B et al. Laryngoscope. 2026
HPV-relatedAll Stages2026
Spatial transcriptomics of immune ecotypes for predicting immunotherapy outcomes in head and neck squamous cell carcinoma.
Xin Y et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Avoiding prophylactic tracheostomies in head and neck surgeries with reconstructive free flaps: An institutional shift in practice.
Liu AQ et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Biomarkers Associated With Extranodal Extension (ENE) in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Systematic Review.
Williams LC et al. Head Neck. 2026
HPV-relatedAll Stages2026
Intraoperative Indocyanine Green Fluorescence Enables Primary Tumor Localization and Treatment De-Escalation in SCCUP: A Case Report.
Bellamkonda N et al. Head Neck. 2026
Anti-EGFRadvanced2026
Molecular and immune landscape of recurrent and/or distant metastatic squamous cell carcinoma of the head and neck: an EORTC/IMMUCAN project.
van der Elst A et al. Clin Cancer Res. 2026
GeneralAll Stages2026
Prognostic value of early Epstein-Barr Virus DNA response in patients with locoregionally advanced nasopharyngeal carcinoma.
Du C et al. Oral Oncol. 2026
laryngealEarly (I-II)2026
History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma.
Katoh M et al. Head Neck. 2026
ImmunotherapyAll Stages2026
Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.
Mirghani H et al. J Clin Oncol. 2026
HPV-relatedadvanced2026
Veteran oropharyngeal cancer outcomes in the modern era: a multi-institutional retrospective analysis.
Little S et al. Oral Oncol. 2026
ImmunotherapyEarly (I-II)2026
Neoadjuvant chemoimmunotherapy improves response rates in head and neck cancer.
Anderson JL et al. Clin Cancer Res. 2026
Immunotherapyadvanced2026
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Rischin D et al. Clin Cancer Res. 2026
HPV-relatedAll Stages2026
Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal Cancer.
Han JE et al. Int J Radiat Oncol Biol Phys. 2026
Immunotherapyadvanced2026
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.
Licitra L et al. J Clin Oncol. 2026
HPV-relatedAll Stages2026
Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.
Chelvarajah RC et al. Head Neck. 2026
Anti-EGFRAll Stages2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trial.
Ringash J et al. Int J Radiat Oncol Biol Phys. 2026
HPV-relatedEarly (I-II)2026
Transoral robotic surgery versus definitive (Chemo)radiotherapy in early HPV-positive oropharyngeal cancer: A systematic review and meta-analysis of oncologic outcomes.
Carvalho WA et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal Carcinoma.
Gili R et al. Head Neck. 2026
Generaladvanced2026
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma.
Colevas AD et al. ESMO Open. 2026
GeneralEarly (I-II)2026
The prognostic significance of the 'Worst Pattern of Invasion' in oral cancers-an international collaborative multicentre analysis.
Roy P et al. Oral Oncol. 2026
laryngealAll Stages2026
Rare laryngeal tumors: A retrospective bicentric study on 74 patients and systematic review.
Chu F et al. Oral Oncol. 2026
HPV-relatedEarly (I-II)2026
Long-term swallowing outcomes following transoral robotic surgery for oropharyngeal cancer - Five years and beyond.
Wojtera BP et al. Oral Oncol. 2026
HPV-relatedadvanced2026
Tumour microenvironment diversity of HNSCC and the molecular landscape of recurrent disease.
Steele K et al. Oral Oncol. 2026
HPV-relatedAll Stages2026
Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC.
Hose L et al. Br J Cancer. 2026
HPV-relatedAll Stages2026
Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCC.
Gencel-Augusto J et al. Head Neck. 2026
HPV-relatedAll Stages2026
Long-Term outcomes of induction chemotherapy-guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trials.
Lovett JT et al. Oral Oncol. 2026